UBS Group
CPXX

UBS Group’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

UBS Group’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-99,000
Closed -$2.99M – 8326
2016
Q2 		$2.99M Buy
+99,000
New +$2.01M ﹤0.01% 2431

UBS Group's CPXX Position: Q3 2016 in Review

UBS Group sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 600 shares — an estimated $18K sold.

UBS Group first reported a position in CPXX in Q2 2015 and held it in 4 quarters. The position peaked at $18K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • UBS Group reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • UBS Group sold 600 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $18K.
  • UBS Group first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2015 and held it in 4 quarters.
  • UBS Group's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $18K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.